Pfizer (PFE): Rep. Roger Williams (TX25) disclosed a purchase $1K–$15K
Rep. Roger Williams (TX25) disclosed a purchase of Pfizer in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 103 days
- Disclosure lag
- Traded
- Mar 1, 2024
- Disclosed
- Jun 12, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 11, 2023CongressDisclosed sale of PFE — reported range $1,001 - $15,000
- Dec 12, 2023Congress · 1 personMembers of Congress: 3 sales
- Dec 14, 2023CongressDisclosed sale of PFE — reported range $1,001 - $15,000
- Dec 18, 2023CongressDisclosed partial sale of PFE — reported range $1,001 - $15,000
- Dec 20, 2023CongressDisclosed purchase of PFE — reported range $1,001 - $15,000
- Dec 28, 2023Congress · 1 personMembers of Congress: 2 sales
- Feb 12, 2024CongressDisclosed purchase of PFE — reported range $1,001 - $15,000
- Feb 27, 2024CongressDisclosed purchase of PFE — reported range $1,001 - $15,000
- Mar 1, 2024 · this disclosureCongressDisclosed purchase of PFE — reported range $1,001 - $15,000
What came next
- Mar 1, 2024CongressDisclosed sale of PFE — reported range $1,001 - $15,000
- Mar 4, 2024CongressDisclosed sale of PFE — reported range $1,001 - $15,000
- Mar 6, 2024FDAFDA drug approval: Besponsa
- Mar 7, 2024FDAFDA drug approval: Talzenna
- Apr 29, 2024FDAFDA drug approval: Tivdak
- May 3, 2024CongressDisclosed sale of PFE — reported range $15,001 - $50,000
- May 20, 2024FDARecall: Labetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intravenous Injection Only…
- May 20, 2024FDARecall: Buprenorphine Hydrochloride Injection, 0.3 mg base/mL, 1 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intramuscular or Intravenous Use,…
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Pfizer
OQRO holds no insider, Congress, fund or contract record for Pfizer dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PFE page.
Other recent filings by Rep. Roger Williams (TX25)
- House Clerk periodic transaction report at Chevron (CVX)Jan 15, 2026
- House Clerk periodic transaction report at Diamondback Energy (FANG)Jan 15, 2026
- House Clerk periodic transaction report at JPMorgan Chase (JPM)Jan 15, 2026
- House Clerk periodic transaction report at RTX (RTX)Jan 15, 2026
- House Clerk periodic transaction report at Sunshine Biopharma (SBFM)Jun 12, 2024
The full history of Rep. Roger Williams (TX25) is on the profile page.
How this filing works
Explore the data
Other disclosures at Pfizer
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its PFE page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
